Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial

Author: Waller Cornelius   Bronchud Miguel   Mair Stuart   Challand Rodeina  

Publisher: Springer Publishing Company

ISSN: 0939-5555

Source: Annals of Hematology, Vol.89, Iss.10, 2010-10, pp. : 971-978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next